University of Maryland researchers work on flu treatment

Modern medication doesn’t provide a lot to counter the distress introduced on by the flu, however researchers on the University of Maryland School of Medicine say they’re on to one thing promising.

It’s a protein that not solely might ease signs of influenza and save lives however shield in opposition to different nasty infections.

“Every year, thousands of people across the country die from the flu or its complications, despite widespread use of annual influenza vaccines,” stated Daniel J. Prantner, a Maryland scientist and lead writer of a research in regards to the protein retrocyclin-101. “We think that this protein could lead to medicines that could be a powerful tool in the battle against this disease, and against inflammation in general.”

Prantner confirmed that retrocyclin may forestall immune cells from turning into contaminated with the flu virus and cease the extreme irritation liable for such signs as fever, ache, lethargy and troubled respiration.

Retrocyclin works by blocking activation of TLR4, a receptor on human white blood cells that acknowledges the approaching hazard from an an infection.

Once TLR4 will get a sign, it tells the cells to answer the risk and produce irritation, some of which is important to battle an invading virus, micro organism or fungus. Too a lot irritation, nonetheless, wreaks havoc on the physique. When given to sick sufferers, the retrocyclin would cease the overreaction.

Prantner’s research, printed just lately within the Journal of Leukocyte Biology, demonstrated that retrocyclin shut down the flu in a petri dish full of human cells and in mice.

Another investigator on the mission, Alfredo Garzino-Demo from the medical faculty’s Institute for Human Virology, will proceed testing it on different infections equivalent to these from Zika, Ebola and Dengue viruses.

Leave a Reply

Your email address will not be published. Required fields are marked *